Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
siRNA
Biotech
AstraZeneca pays CSPC $30M to form kidney drug discovery pact
AstraZeneca has committed up to $1.7 billion in milestones to jointly discover and develop two kidney disease drug candidates with CSPC.
Nick Paul Taylor
Jul 3, 2026 8:00am
Novartis dystrophy data tee up regulatory talks on Avidity drug
Jun 12, 2026 4:30am
Alnylam pays Inceptive $30M to transform siRNA design
Jun 4, 2026 4:13am
AstraZeneca FLAP inhibitor flunks ph. 2 asthma trial
Apr 29, 2026 8:38am
The 'diabolical' molecule set to become biotech's next gold rush
Apr 9, 2026 8:00am
Wave crashes after obesity trial tracks 1% dip in body weight
Mar 26, 2026 9:20am
